文献速递类风湿关节炎

胰岛素抵抗通路与类风湿关节炎疾病活动相关并可经代谢重编程实现疾病修饰

Insulin-Resistant Pathways Are Associated With Disease Activity in Rheumatoid Arthritis and Are Subject to Disease Modification Through Metabolic Reprogramming: A Potential Novel Therapeutic Approach.
PubMed 文献 · Arthritis Rheumatol · 2020-05-10

在爱尔兰RA队列中,胰岛素抵抗独立关联BMI与28关节肿胀计数;RA滑膜GLUT-1表达高于OA而GLUT-4在衬里层低于OA;二甲双胍经AMPK改变滑膜成纤维细胞代谢并减少IL-6、IL-8、MCP-1产生,提示代谢重编程可能成为RA治疗新方向。

要点

  • 胰岛素抵抗独立关联RA的BMI与SJC28,提示葡萄糖可用性与炎症相互作用。
  • RA滑膜GLUT-1表达高于OA,而衬里层GLUT-4表达低于OA。
  • 二甲双胍经AMPK改变RA滑膜成纤维细胞代谢并减少促炎介质产生。

核心结论

  • 胰岛素抵抗与RA的BMI和滑膜炎显著相关,提示葡萄糖可用性与炎症之间存在独特相互作用。
  • 二甲双胍对促炎机制的影响提示AMPK修饰化合物可能用于RA治疗。

研究设计与样本

  • 在爱尔兰RA队列中评估疾病活动与心血管危险因素(含胰岛素抵抗和BMI)。
  • 用免疫组化检测RA与OA滑膜组织GLUT-1和GLUT-4活性。
  • 用ELISA定量离体RA滑膜外植体和原代滑膜成纤维细胞培养上清的自发性促炎介质释放。
  • 用Western blotting分析p-AMPK与GLUT-1蛋白表达,用细胞外通量分析评估糖酵解与氧化磷酸化。

主要发现

  • 胰岛素抵抗独立关联BMI(B 0.113 [95%CI 0.059-0.167];P < 0.001;n = 61)。
  • 胰岛素抵抗独立关联SJC28(B 0.114 [95%CI 0.032-0.197];P = 0.008;n = 61)。
  • RA滑膜(n = 26)GLUT-1表达高于OA滑膜(n = 16)(P = 0.0003),衬里、亚衬里和血管区表达增加。
  • RA衬里层(n = 21)GLUT-4表达低于OA衬里层(n = 8)(P = 0.0358)。
  • 二甲双胍存在时SFs中GLUT-1蛋白表达降低伴p-AMPK蛋白表达升高(n = 4)。

临床怎么用

  • 对RA患者评估胰岛素抵抗和BMI可能有助于识别滑膜炎更活跃的亚群。
  • 二甲双胍或AMPK修饰化合物作为RA疾病修饰治疗的潜力值得进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate a role for insulin-resistant pathways in inflammation and therapeutic targeting for disease modification in rheumatoid arthritis (RA). METHODS: RA disease activity and cardiovascular risk factors, including insulin resistance and body mass index (BMI), were assessed in an Irish RA cohort. Glucose transporter 1 (GLUT-1) and GLUT-4 activity in RA and osteoarthritis (OA) synovial tissue was examined using immunohistochemistry. Spontaneous release of proinflammatory mediators from ex vivo RA synovial explants and primary synovial fibroblast (SF) cell culture supernatants was quantified by enzyme-linked immunosorbent assay. Phosphorylated AMP-activated protein kinase (p-AMPK) and GLUT-1 protein expression was analyzed by Western blotting. Cellular glycolytic and oxidative phosphorylation was assessed using extracellular flux analysis. RESULTS: Insulin resistance was independently associated with both BMI (unstandardized coefficient B 0.113 [95% confidence interval (95% CI) 0.059-0.167]; P < 0.001) (n = 61) and swollen joint count in 28 joints (SJC28) (B 0.114 [95% CI 0.032-0.197]; P = 0.008) (n = 61). Increased GLUT-1 expression in RA synovium (n = 26) versus OA synovium (n = 16) was demonstrated (P = 0.0003), with increased expression in the lining, sublining, and vascular regions. In contrast, decreased GLUT-4 expression in the RA lining layer (n = 21) versus the OA lining layer (n = 8) was observed (P = 0.0358). Decreased GLUT-1 protein expression was observed in parallel with increased p-AMPK protein expression in SFs in the presence of metformin (n = 4). Metformin increased glycolytic activity and decreased oxidative phosphorylation in RASFs (n = 7) (P < 0.05 for both). Metformin or aminoimidazole carboxamide ribonucleotide presence decreased spontaneous production of interleukin-6 (IL-6), IL-8, and monocyte chemotactic protein 1 in RA synovial explants and SFs (n = 5-7). CONCLUSION: Insulin resistance is significantly associated with BMI and synovitis in RA, suggesting distinct interplay between glucose availability and inflammation in RA. Furthermore, the effect of metformin on proinflammatory mechanisms suggests a role for AMPK-modifying compounds in the treatment of RA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Gallagher L, Cregan S, Biniecka M, et al. Insulin-Resistant Pathways Are Associated With Disease Activity in Rheumatoid Arthritis and Are Subject to Disease Modification Through Metabolic Reprogramming: A Potential Novel Therapeutic Approach. Arthritis Rheumatol. 2020. PMID: 31840936. doi:10.1002/art.41190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。